Position | Description |
---|---|
245 | Not glycosylated |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
55 | N-linked (GlcNAc...) asparagine |
|
||
93 | N-linked (GlcNAc...) asparagine | |||
197 |
|
|||
221 | N-linked (GlcNAc...) asparagine |
|
||
245 | N-linked (GlcNAc...) asparagine |
|
||
320 |
|
|||
329 |
|
|||
335 |
|
|||
350 | N-linked (GlcNAc...) asparagine |
|
||
352 | O-linked (GlcNAc) threonine |
|
Pathway Name | Organism |
---|---|
Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
Interleukin-6 signaling | Homo sapiens |
MAPK1 (ERK2) activation | Homo sapiens |
MAPK3 (ERK1) activation | Homo sapiens |
Potential therapeutics for SARS | Homo sapiens |
Transcriptional regulation of granulopoiesis | Homo sapiens |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024